New Animal Drugs; Ractopamine, 1275-1276 [2010-208]
Download as PDF
Federal Register / Vol. 75, No. 6 / Monday, January 11, 2010 / Rules and Regulations
cprice-sewell on DSK2BSOYB1PROD with RULES
florfenicol and flunixin meglumine in
cattle.
DATES: This rule is effective January 11,
2010.
FOR FURTHER INFORMATION CONTACT:
Cindy L. Burnsteel, Center for
Veterinary Medicine (HFV–130), Food
and Drug Administration, 7500 Standish
Pl., Rockville, MD 20855, 240–276–
8341, e-mail:
cindy.burnsteel@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Intervet,
Inc., 56 Livingston Ave., Roseland, NJ
07068, filed NADA 141–299 that
provides for use RESFLOR GOLD
(florfenicol and flunixin meglumine), a
combination injectable solution, for
treatment of bovine respiratory disease
(BRD) associated with Mannheimia
haemolytica, Pasteurella multocida, and
Histophilus somni, and control of BRDassociated pyrexia in beef and nonlactating dairy cattle. The NADA is
approved as of November 23, 2009, and
the regulations in 21 CFR part 522 are
amended by adding § 522.956 to reflect
the approval.
In accordance with the freedom of
information provisions of 21 CFR part
20 and 21 CFR 514.11(e)(2)(ii), a
summary of safety and effectiveness
data and information submitted to
support approval of this application
may be seen in the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852, between 9
a.m. and 4 p.m., Monday through
Friday.
Under section 512(c)(2)(F)(ii) of the
Federal Food, Drug, and Cosmetic Act
(21 U.S.C. 360b(c)(2)(F)(ii)), this
approval qualifies for 3 years of
marketing exclusivity beginning on the
date of approval.
The agency has determined under 21
CFR 25.33 that this action is of a type
that does not individually or
cumulatively have a significant effect on
the human environment. Therefore,
neither an environmental assessment
nor an environmental impact statement
is required.
This rule does not meet the definition
of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because
it is a rule of ‘‘particular applicability.’’
Therefore, it is not subject to the
congressional review requirements in 5
U.S.C. 801–808.
List of Subjects in 21 CFR Part 522
Animal drugs.
■ Therefore, under the Federal Food,
Drug, and Cosmetic Act and under
authority delegated to the Commissioner
of Food and Drugs and redelegated to
the Center for Veterinary Medicine, 21
CFR part 522 is amended as follows:
VerDate Nov<24>2008
15:08 Jan 08, 2010
Jkt 220001
PART 522—IMPLANTATION OR
INJECTABLE DOSAGE FORM NEW
ANIMAL DRUGS
1. The authority citation for 21 CFR
part 522 continues to read as follows:
■
Authority: 21 U.S.C. 360b.
■
2. Add § 522.956 to read as follows:
§ 522.956
Florfenicol and flunixin.
(a) Specifications. Each milliliter (mL)
of solution contains 300 milligrams (mg)
florfenicol and 16.5 mg flunixin (27.37
mg flunixin meglumine).
(b) Sponsor. See No. 000061 in
§ 510.600(c) of this chapter for use as in
paragraph (d) of this section.
(c) Tolerances. See §§ 556.283 and
556.286 of this chapter.
(d) Conditions for use in cattle—(1)
Amount. 40 mg florfenicol/kg body
weight (BW) and 2.2 mg flunixin/kg BW
(equivalent to 2 mL/15 kg BW or 6 mL/
100 lbs) once, by subcutaneous
injection.
(2) Indications for use. For treatment
of bovine respiratory disease (BRD)
associated with Mannheimia
haemolytica, Pasteurella multocida, and
Histophilus somni, and control of BRDassociated pyrexia in beef and nonlactating dairy cattle.
(3) Limitations. Federal law restricts
this drug to use by or on the order of
a licensed veterinarian. Animals
intended for human consumption must
not be slaughtered within 38 days of
treatment. Do not use in female dairy
cattle 20 months of age or older. Use of
florfenicol in this class of cattle may
cause milk residues. A withdrawal
period has not been established in
preruminating calves. Do not use in
calves to be processed for veal.
Dated: December 31, 2009.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. 2010–209 Filed 1–8–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
21 CFR Part 558
[Docket No. FDA–2009–N–0665]
New Animal Drugs; Ractopamine
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Final rule.
SUMMARY: The Food and Drug
Administration (FDA) is amending the
animal drug regulations to reflect
PO 00000
Frm 00007
Fmt 4700
Sfmt 4700
1275
approval of a supplemental new animal
drug application (NADA) filed by
Elanco Animal Health, A Division of Eli
Lilly & Co. The supplemental NADA
provides for administering ractopamine
hydrochloride Type C medicated feeds
as a top dress to cattle fed in
confinement for slaughter.
DATES: This rule is effective January 11,
2010.
FOR FURTHER INFORMATION CONTACT:
Suzanne J. Sechen, Center for Veterinary
Medicine (HFV–126), Food and Drug
Administration, 7500 Standish Pl.,
Rockville, MD 20855, 240–276–8105,
e-mail: suzanne.sechen@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Elanco
Animal Health, A Division of Eli Lilly
& Co., Lilly Corporate Center,
Indianapolis, IN 46285, filed a
supplement to NADA 141–221 that
provides for use of OPTAFLEXX 45
(ractopamine hydrochloride) Type A
medicated articles to formulate Type B
and Type C medicated feeds
administered to cattle fed in
confinement for slaughter for increased
rate of weight gain and improved feed
efficiency during the last 28 to 42 days
on feed. The supplement provides for
feeding ractopamine hydrochloride
Type C medicated feed as a top dress.
The supplemental NADA is approved as
of December 11, 2009, and the
regulations in 21 CFR 558.500 are
amended to reflect the approval.
In accordance with the freedom of
information provisions of 21 CFR part
20 and 21 CFR 514.11(e)(2)(ii), a
summary of safety and effectiveness
data and information submitted to
support approval of this application
may be seen in the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852, between 9
a.m. and 4 p.m., Monday through
Friday.
The agency has determined under 21
CFR 25.33 that this action is of a type
that does not individually or
cumulatively have a significant effect on
the human environment. Therefore,
neither an environmental assessment
nor an environmental impact statement
is required.
Under section 512(c)(2)(F)(iii) of the
Federal Food, Drug, and Cosmetic Act
(21 U.S.C. 360b(c)(2)(F)(iii)), this
supplemental approval qualifies for 3
years of marketing exclusivity beginning
on the date of approval.
This rule does not meet the definition
of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because
it is a rule of ‘‘particular applicability.’’
Therefore, it is not subject to the
congressional review requirements in 5
U.S.C. 801–808.
E:\FR\FM\11JAR1.SGM
11JAR1
1276
Federal Register / Vol. 75, No. 6 / Monday, January 11, 2010 / Rules and Regulations
List of Subjects in 21 CFR Part 558
Animal drugs, Animal feeds.
Therefore, under the Federal Food,
Drug, and Cosmetic Act and under the
authority delegated to the Commissioner
of Food and Drugs and redelegated to
the Center for Veterinary Medicine, 21
CFR part 558 is amended as follows:
■
remove ‘‘Ractopame’’ and in its place
add ‘‘Ractopamine’’; and add paragraph
(e)(2)(xi) to read as follows:
1. The authority citation for 21 CFR
part 558 continues to read as follows:
§ 558.500
■
*
2. In § 558.500, in paragraph (e)(2), in
the heading of the first table column,
■
*
*
*
*
*
Dated: December 31, 2009.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. 2010–208 Filed 1–8–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF THE INTERIOR
Minerals Management Service
30 CFR Part 250
[Docket ID MMS–2007–OMM–0066]
RIN 1010–AD45
Requirements for Subsurface Safety
Valve Equipment
cprice-sewell on DSK2BSOYB1PROD with RULES
AGENCY: Minerals Management Service
(MMS), Interior.
ACTION: Final rule.
SUMMARY: The MMS is incorporating by
reference the Eleventh Edition of the
American Petroleum Institute’s
Specification for Subsurface Safety
Valve Equipment (API Spec 14A) into
its regulations. The MMS is
incorporating the Eleventh Edition of
API Spec 14A because it updated the
design validation and functional testing
requirements, incorporated new design
changes, and corrected ambiguous areas
open to misinterpretation. These
changes will ensure that lessees and
operators use the best available and
safest technologies while operating in
the Outer Continental Shelf. The rule
will also require that lessees and
operators provide supporting design
verification information for subsurface
safety valves intended for use in high
pressure high temperature
environments.
DATES: Effective Date: This final rule is
effective on February 10, 2010. The
VerDate Nov<24>2008
19:27 Jan 08, 2010
Jkt 220001
*
*
Frm 00008
Fmt 4700
*
*
Sfmt 4700
*
Sponsor
*
Top dress in a minimum of 1.0 lb
of medicated feed.
incorporation by reference of the
publication listed in the regulation is
approved by the Director of the Federal
Register as of February 10, 2010.
FOR FURTHER INFORMATION CONTACT:
Wilbon Rhome, Office of Offshore
Regulatory Programs, Regulations and
Standards Branch at (703) 787–1587.
SUPPLEMENTARY INFORMATION: The MMS
uses standards, specifications, and
recommended practices developed by
standard-setting organizations and the
oil and gas industry as a means of
establishing requirements for activities
on the OCS. This practice, known as
incorporation by reference, allows us to
incorporate the provisions of technical
standards into the regulations. The legal
effect of incorporation by reference is
that the material is treated as if the
entire document were published in the
Federal Register. This material, like any
other properly issued regulation, then
has the force and effect of law. We hold
operators/lessees accountable for
complying with the documents
incorporated by reference in our
regulations. We currently incorporate by
reference 97 private sector consensus
standards into the offshore operating
regulations. The regulations at 1 CFR
part 51 govern how we and other
Federal agencies incorporate various
documents by reference. Agencies may
only incorporate a document by
reference by publishing the document
title and affirmation/reaffirmation date
in the Federal Register. Agencies must
also gain approval from the Director of
the Federal Register for each
publication incorporated by reference.
Incorporation by reference of a
document or publication is limited to
the specific edition, supplement, or
addendum cited in the regulations.
This rule adds the following API
document to those currently
PO 00000
*
Limitations
Cattle fed in confinement for
slaughter: As in paragraph
(e)(2)(i) of this section.
*
*
*
Ractopamine.
*
*
(e) * * *
(2) Cattle—
Indications for use
*
(xi) Not to exceed 800; to provide
70 to 400 mg/head/day.
*
*
Authority: 21 U.S.C. 360b, 371.
Combination in
grams/ton
Ractopamine in grams/ton
*
PART 558—NEW ANIMAL DRUGS FOR
USE IN ANIMAL FEEDS
*
000986
*
incorporated by reference in MMS
regulations:
ANSI/API Specification 14A,
Specification for Subsurface Safety
Valve Equipment, Eleventh Edition,
October 2005, Effective Date: May 1,
2006; also available as ISO 10432: 2004,
Product No. GX14A11.
The MMS has reviewed this
document and determined that
incorporating it into regulations ensures
that industry uses the best available and
safest technologies for downhole safety
valves.
This final rule updates the
requirements for subsurface safety
valves operating in high pressure, high
temperature (HPHT) environments in 30
CFR part 250 Subpart A—General and
Subpart H—Oil and Gas Production
Safety Systems. Subpart A is amended
to incorporate by reference ANSI/API
Specification 14A, Specification for
Subsurface Safety Valve (SSSV)
Equipment. The MMS is also adding a
new section (30 CFR 250.807) to
Subpart H that identifies additional
safety valve information requirements
for HPHT environments.
The Eleventh Edition of API Spec.
14A contains significant technological
and design changes that will increase
the safety of downhole operations in the
Outer Continental Shelf (OCS). The
updated API Spec. 14A is an
improvement over the current API Spec.
14A, Tenth Edition, incorporated in the
regulations because it does the
following:
• Strengthens the guidelines for
preparation of a functional specification
by the user/purchaser to submit to the
manufacturer/supplier when ordering
equipment addressed by this standard.
Functional characteristics in the
specification must include, but are not
limited to, well parameters, operational
parameters, environmental
E:\FR\FM\11JAR1.SGM
11JAR1
Agencies
[Federal Register Volume 75, Number 6 (Monday, January 11, 2010)]
[Rules and Regulations]
[Pages 1275-1276]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-208]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 558
[Docket No. FDA-2009-N-0665]
New Animal Drugs; Ractopamine
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect approval of a supplemental new animal drug
application (NADA) filed by Elanco Animal Health, A Division of Eli
Lilly & Co. The supplemental NADA provides for administering
ractopamine hydrochloride Type C medicated feeds as a top dress to
cattle fed in confinement for slaughter.
DATES: This rule is effective January 11, 2010.
FOR FURTHER INFORMATION CONTACT: Suzanne J. Sechen, Center for
Veterinary Medicine (HFV-126), Food and Drug Administration, 7500
Standish Pl., Rockville, MD 20855, 240-276-8105, e-mail:
suzanne.sechen@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Elanco Animal Health, A Division of Eli
Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285, filed a
supplement to NADA 141-221 that provides for use of OPTAFLEXX 45
(ractopamine hydrochloride) Type A medicated articles to formulate Type
B and Type C medicated feeds administered to cattle fed in confinement
for slaughter for increased rate of weight gain and improved feed
efficiency during the last 28 to 42 days on feed. The supplement
provides for feeding ractopamine hydrochloride Type C medicated feed as
a top dress. The supplemental NADA is approved as of December 11, 2009,
and the regulations in 21 CFR 558.500 are amended to reflect the
approval.
In accordance with the freedom of information provisions of 21 CFR
part 20 and 21 CFR 514.11(e)(2)(ii), a summary of safety and
effectiveness data and information submitted to support approval of
this application may be seen in the Division of Dockets Management
(HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852, between 9 a.m. and 4 p.m., Monday through Friday.
The agency has determined under 21 CFR 25.33 that this action is of
a type that does not individually or cumulatively have a significant
effect on the human environment. Therefore, neither an environmental
assessment nor an environmental impact statement is required.
Under section 512(c)(2)(F)(iii) of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 360b(c)(2)(F)(iii)), this supplemental approval
qualifies for 3 years of marketing exclusivity beginning on the date of
approval.
This rule does not meet the definition of ``rule'' in 5 U.S.C.
804(3)(A) because it is a rule of ``particular applicability.''
Therefore, it is not subject to the congressional review requirements
in 5 U.S.C. 801-808.
[[Page 1276]]
List of Subjects in 21 CFR Part 558
Animal drugs, Animal feeds.
0
Therefore, under the Federal Food, Drug, and Cosmetic Act and under the
authority delegated to the Commissioner of Food and Drugs and
redelegated to the Center for Veterinary Medicine, 21 CFR part 558 is
amended as follows:
PART 558--NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS
0
1. The authority citation for 21 CFR part 558 continues to read as
follows:
Authority: 21 U.S.C. 360b, 371.
0
2. In Sec. 558.500, in paragraph (e)(2), in the heading of the first
table column, remove ``Ractopame'' and in its place add
``Ractopamine''; and add paragraph (e)(2)(xi) to read as follows:
Sec. 558.500 Ractopamine.
* * * * *
(e) * * *
(2) Cattle--
------------------------------------------------------------------------
Ractopamine in Combination Indications
grams/ton in grams/ton for use Limitations Sponsor
------------------------------------------------------------------------
* * * * * * *
------------------------------------------------------------------------
(xi) Not to ............. Cattle fed in Top dress in 000986
exceed 800; confinement a minimum of
to provide 70 for 1.0 lb of
to 400 mg/ slaughter: medicated
head/day. As in feed.
paragraph
(e)(2)(i) of
this
section.
------------------------------------------------------------------------
* * * * * * *
------------------------------------------------------------------------
* * * * *
Dated: December 31, 2009.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. 2010-208 Filed 1-8-10; 8:45 am]
BILLING CODE 4160-01-S